Author Question: A patient is taking diethylcarbamazine (Hetrazan) to treat a filarial infestation. The patient ... (Read 58 times)

Alygatorr01285 · **on:** Jul 23, 2018

A patient is taking diethylcarbamazine (Hetrazan) to treat a filarial infestation. The patient reports intense itching and a rash after several days of therapy. What will the nurse tell this patient?

a. These symptoms are caused by death of the parasite.
b. This is a minor, direct adverse effect of the drug.
c. This is a sign the infestation is worsening.
d. This warrants discontinuation of the drug.

Question 2

A patient with strongyloidiasis is being treated with ivermectin (Stromectol). What will the nurse expect to teach this patient?

a. A Mazotti-type reaction is likely.
b. Hypotension is a common side effect of the drug.
c. The drug should be taken every 6 to 12 months until symptoms have cleared.
d. The drug should be taken with water for 1 to 2 days.

scikid · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

ANS: A
Indirect effects of therapy with diethylcarbamazine, such as itching and a rash, are the result of death of the parasite. These effects are transient. They are not direct effects of the drug. They do not indicate worsening of the infestation. They do not warrant discontinuation of the drug.

Answer to Question 2

ANS: D
Ivermectin is given for 1 to 2 days to treat strongyloidiasis. A Mazotti-type reaction occurs when ivermectin is used to treat onchocerciasis. Hypotension is not a common side effect. Ivermectin is given every 6 to 12 months when treating onchocerciasis.